Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 3 3Phase 1 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Liver Neoplasms 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Cyclophosphamide 299Cisplatin 298Paclitaxel 257Radiotherapy 255Fluorouracil 234Carboplatin 234Docetaxel 230Doxorubicin 216Dexamethasone 166Gemcitabine 156Vincristine 147Etoposide 136Leucovorin 133Capecitabine 129Bevacizumab 129Prednisone 125Rituximab 118Methotrexate 118Cytarabine 110Filgrastim 99Trastuzumab 97Oxaliplatin 96pembrolizumab 83Pemetrexed 73Epirubicin 70Tamoxifen 69Drug Therapy 69Irinotecan 65Granulocyte Colony-Stimulating Factor 60Daunorubicin 58

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Completed × Chewing Gum × Clear all
NCT02649153 2024-01-23

SP/GC-HCC

Guangxi Medical University

Phase 3 Completed
240 enrolled
Gastrointestinal

Liver Neoplasms

NCT02438436 2023-01-30

SD/GC-HCC

Guangxi Medical University

Phase 3 Completed
180 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT02813278 2016-06-27

SMD/POI

Guangxi Medical University

Phase 3 Completed
600 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡